Pharmaceutical Industry Reports Telmisartan Market Size, Share, Outlook, and Analy Кликнуть для чтения
  • Комментарии

Pharmaceutical Industry Reports

Telmisartan Market Size, Share, Outlook, and Analy

Опубликовано в "Здоровье и фитнес", язык - English. 8 страниц.
Telmisartan was approved for use in the U.S., for treatment of hypertension in 1998. Telmisartan is available in 20, 40 and 80 mg tablets in generic forms and under the trade name, Micardis. Еще
Nanobodies are considered to be one of the best technology in the fields of research, diagnostics and therapy especially in cancer research. Еще
Показать тэги

Другие выпуски “Pharmaceutical Industry Reports”

Просмотреть все выпуски